Advanos Announces Board Approval of Q1 2026 Consolidated Financial Report

Advanos' board of directors approved the Q1 2026 consolidated financial report. Key figures include cumulative operating revenue of NT$3.03 billion and basic EPS of NT$0.76.
その他NQ 0/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: May 5, 2026 at 09:00
  • 🔍 Collected: May 6, 2026 at 08:00 (23h 0m after Published)
  • 🤖 AI Analyzed: May 6, 2026 at 08:41 (41 min after Collected)
1. Date of Report to or Resolution by the Board of Directors: May 5, 2026
2. Date of Approval by the Audit Committee: May 5, 2026
3. Reporting Period of Financial Report or Annual Self-Audited Financial Information:
From January 1, 2026 to March 31, 2026
4. Cumulative Operating Revenue from January 1 to the end of this period (in thousands of NTD): 3,030,612
5. Cumulative Operating Gross Profit (Loss) from January 1 to the end of this period (in thousands of NTD): 754,408
6. Cumulative Operating Income (Loss) from January 1 to the end of this period (in thousands of NTD): 168,760
7. Cumulative Pre-tax Net Profit (Loss) from January 1 to the end of this period (in thousands of NTD): 160,589
8. Cumulative Net Profit (Loss) for this period from January 1 to the end of this period (in thousands of NTD): 120,365
9. Cumulative Net Profit (Loss) Attributable to Owners of the Parent from January 1 to the end of this period (in thousands of NTD): 86,809
10. Cumulative Basic Earnings Per Share (Loss) from January 1 to the end of this period (in NTD): 0.76
11. Total Assets at Period End (in thousands of NTD): 13,261,955
12. Total Liabilities at Period End (in thousands of NTD): 7,705,318
13. Equity Attributable to Owners of the Parent at Period End (in thousands of NTD): 3,228,548
14. Other Matters to be Specified: None